2021
DOI: 10.17323/2500-2597.2021.3.52.65
|View full text |Cite
|
Sign up to set email alerts
|

Transformation of Value in Innovative Business Models: The Case of Pharmaceutical Market

Abstract: Creating and developing innovative business models (BM) is currently one of the key success factors for contemporary business. Rapid complex changes in the world reemphasize the need to better understand how BM can be successfully innovated in different markets. The digital component of BM innovation comes under a special spotlight, using the example of a company within the pharmaceutical industry. In particular, this study demonstrates how BM innovation can be developed and implemented in practice within the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 5 publications
0
6
0
2
Order By: Relevance
“…pandemic, for instance, has affected military-political interactions and health assistance conditions in specific contexts, as noted by Ayvazyan (2021) and Bagci et al (2022), respectively. It has also had an impact on medical research and business models, as discussed by Butenco et al (2020) and Klimanov et al (2021), respectively. The Russia-Ukraine crisis has further complicated these global contexts, particularly concerning various aspects of human health, as highlighted by Chaaya et al (2022) and Devi (2021).…”
Section: S405mentioning
confidence: 99%
“…pandemic, for instance, has affected military-political interactions and health assistance conditions in specific contexts, as noted by Ayvazyan (2021) and Bagci et al (2022), respectively. It has also had an impact on medical research and business models, as discussed by Butenco et al (2020) and Klimanov et al (2021), respectively. The Russia-Ukraine crisis has further complicated these global contexts, particularly concerning various aspects of human health, as highlighted by Chaaya et al (2022) and Devi (2021).…”
Section: S405mentioning
confidence: 99%
“…Em relação às tecnologias digitais destaca-se os estudos de Klimanov et al (2021), onde o uso da inteligência artificial (IA) na indústria farmacêutica afeta os principais processos de negócio. Os autores enfatizam que os próximos anos poderão gerar um boom no desenvolvimento e aplicação de novas tecnologias como a inteligência artificial.…”
Section: Tecnologias Digitaisunclassified
“…In the contemporary healthcare landscape, adopting e-pharmacies has emerged as a significant and transformative development, signalling a substantial departure from the conventional brick-and-mortar pharmacy model (Klimanov et al, 2021). This transition is propelled by a multi-faceted interplay of factors, encompassing the increasing dependence on digital platforms, the rapid pace of technological progress and the ongoing evolution of consumer preferences (Pieriegud, 2019).…”
Section: Introductionmentioning
confidence: 99%